Previously, Wan et al. (2010) showed that the biological activity of the ATP7B mutant lacking exon 12 was 20% lower than that of wild-type ATP7B in in vitro studies, which might be responsible for a relatively milder disease condition and later onset age in WD patients. Here, ATP7B is linked to Wilson disease.